Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness

Fig. 2

– Frequency of Skipped Exon in BTLA in critically ill mouse model: The skipping of exon 3 is significantly different between critically ill mice (19%, n = 3) and healthy sham controls (0%, n = 3) (FDR =0.0000471413836931, bar graph to the left). The full length isoform is seen 81% of the time in the control mice and 100% of the time in the critically ill mice (bar graph to the right)

Back to article page

Molecular Medicine

ISSN: 1528-3658